APO Research
Talk to an analyst

APO RESEARCH · REPORT

Troponin

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle.

Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death.

A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.

Selected research

Market Outlook & Growth Opportunities

Global Troponin Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchTroponin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Troponin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Troponin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Troponin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Troponin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle.

Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death.

A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.

Read the full market overview

Leading producers in the sector are Abbott, Roche and Siemens Healthcare, with revenue ratios of 28.303%, 21.249% and 10.063% in 2019.

This report provides an overview of the global Troponin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Troponin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Troponin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Troponin market size, projected growth trends, production technologies, key applications, and end-use industries.

Troponin Segment by Company

Abbott

Roche

Siemens Healthcare

Beckman Coulter

Biomerieux

Mitsubishi

Quidel

Getein Biotech

Improve Medical

Response Biomedical

Troponin Segment by Type

Troponin I (TnI)

Troponin T (TnT)

Troponin Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Others

Troponin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Troponin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Troponin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Troponin significant trends, drivers, influence factors in global and regions.

6. To analyze Troponin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Troponin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Troponin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Troponin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Troponin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Troponin industry.

Chapter 3: Detailed analysis of Troponin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Troponin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Troponin Industry Trends Table 2. Troponin Industry Drivers Table 3. Troponin Industry Opportunities and Challenges Table 4. Troponin Industry Restraints Table 5. Global Troponin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Troponin Revenue Share by Company (2021-2026) Table 7. Global Troponin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Troponin Sales Volume Share by Company (2021-2026) Table 9. Global Troponin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Troponin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Troponin Key Company Manufacturing Base & Headquarters Table 12. Global Troponin Company, Product Type & Application Table 13. Global Troponin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Troponin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Troponin I (TnI) Table 18. Significant Companies of Troponin T (TnT) Table 19. Global Troponin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Troponin Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Troponin Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Troponin Sales Volume Share by Type (2021-2026) Table 23. Global Troponin Sales Volume Share by Type (2027-2032) Table 24. Global Troponin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Troponin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Troponin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Troponin Sales Value Share by Type (2021-2026) Table 28. Global Troponin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Myocardial Infarction Table 30. Significant Companies of Acute Coronary Syndrome Table 31. Significant Companies of Others Table 32. Global Troponin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Troponin Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Troponin Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Troponin Sales Volume Share by Application (2021-2026) Table 36. Global Troponin Sales Volume Share by Application (2027-2032) Table 37. Global Troponin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Troponin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Troponin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Troponin Sales Value Share by Application (2021-2026) Table 41. Global Troponin Sales Value Share by Application (2027-2032) Table 42. Global Troponin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Troponin Sales by Region (2021-2026) & (K Units) Table 44. Global Troponin Sales Market Share by Region (2021-2026) Table 45. Global Troponin Sales by Region (2027-2032) & (K Units) Table 46. Global Troponin Sales Market Share by Region (2027-2032) Table 47. Global Troponin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Troponin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Troponin Sales Value Share by Region (2021-2026) Table 50. Global Troponin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Troponin Sales Value Share by Region (2027-2032) Table 52. Global Troponin Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Troponin Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Troponin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Troponin Sales by Country (2021-2026) & (K Units) Table 57. Global Troponin Sales Market Share by Country (2021-2026) Table 58. Global Troponin Sales by Country (2027-2032) & (K Units) Table 59. Global Troponin Sales Market Share by Country (2027-2032) Table 60. Global Troponin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Troponin Sales Value Market Share by Country (2021-2026) Table 62. Global Troponin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Troponin Sales Value Market Share by Country (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Abbott Troponin Product Portfolio Table 68. Abbott Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Roche Troponin Product Portfolio Table 73. Roche Recent Development Table 74. Siemens Healthcare Company Information Table 75. Siemens Healthcare Business Overview Table 76. Siemens Healthcare Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Siemens Healthcare Troponin Product Portfolio Table 78. Siemens Healthcare Recent Development Table 79. Beckman Coulter Company Information Table 80. Beckman Coulter Business Overview Table 81. Beckman Coulter Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Beckman Coulter Troponin Product Portfolio Table 83. Beckman Coulter Recent Development Table 84. Biomerieux Company Information Table 85. Biomerieux Business Overview Table 86. Biomerieux Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Biomerieux Troponin Product Portfolio Table 88. Biomerieux Recent Development Table 89. Mitsubishi Company Information Table 90. Mitsubishi Business Overview Table 91. Mitsubishi Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mitsubishi Troponin Product Portfolio Table 93. Mitsubishi Recent Development Table 94. Quidel Company Information Table 95. Quidel Business Overview Table 96. Quidel Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Quidel Troponin Product Portfolio Table 98. Quidel Recent Development Table 99. Getein Biotech Company Information Table 100. Getein Biotech Business Overview Table 101. Getein Biotech Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Getein Biotech Troponin Product Portfolio Table 103. Getein Biotech Recent Development Table 104. Improve Medical Company Information Table 105. Improve Medical Business Overview Table 106. Improve Medical Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Improve Medical Troponin Product Portfolio Table 108. Improve Medical Recent Development Table 109. Response Biomedical Company Information Table 110. Response Biomedical Business Overview Table 111. Response Biomedical Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Response Biomedical Troponin Product Portfolio Table 113. Response Biomedical Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Troponin Distributors List Table 117. Troponin Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Troponin Product Image Figure 2. Global Troponin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Troponin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Troponin Sales (2021-2032) & (K Units) Figure 5. Global Troponin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Troponin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Troponin I (TnI) Image Figure 10. Troponin T (TnT) Image Figure 11. Global Troponin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Troponin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Troponin Sales Volume Share by Type (2021-2032) Figure 14. Global Troponin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Troponin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Troponin Sales Value Share by Type (2021-2032) Figure 17. Myocardial Infarction Image Figure 18. Acute Coronary Syndrome Image Figure 19. Others Image Figure 20. Global Troponin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Troponin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Troponin Sales Volume Share by Application (2021-2032) Figure 23. Global Troponin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Troponin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Troponin Sales Value Share by Application (2021-2032) Figure 26. Global Troponin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Troponin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Troponin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Troponin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Troponin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Troponin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Troponin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Troponin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Troponin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Troponin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Troponin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Troponin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Troponin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Troponin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Troponin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Troponin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Troponin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Troponin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Troponin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Troponin I (TnI)
  • Troponin T (TnT)
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Others
Companies covered
  • Abbott
  • Roche
  • Siemens Healthcare
  • Beckman Coulter
  • Biomerieux
  • Mitsubishi
  • Quidel
  • Getein Biotech
  • Improve Medical
  • Response Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Troponin Sales Value (2021-2032)
  4. 1.2.2 Global Troponin Sales Volume (2021-2032)
  5. 1.2.3 Global Troponin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Troponin Market Dynamics
  1. 2.1 Troponin Industry Trends
  2. 2.2 Troponin Industry Drivers
  3. 2.3 Troponin Industry Opportunities and Challenges
  4. 2.4 Troponin Industry Restraints
3 Troponin Market by Company
  1. 3.1 Global Troponin Company Revenue Ranking in 2025
  2. 3.2 Global Troponin Revenue by Company (2021-2026)
  3. 3.3 Global Troponin Sales Volume by Company (2021-2026)
  4. 3.4 Global Troponin Average Price by Company (2021-2026)
  5. 3.5 Global Troponin Company Ranking (2024-2026)
  6. 3.6 Global Troponin Company Manufacturing Base and Headquarters
  7. 3.7 Global Troponin Company Product Type and Application
  8. 3.8 Global Troponin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Troponin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Troponin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Troponin Market by Type
  1. 4.1 Troponin Type Introduction
  2. 4.1.1 Troponin I (TnI)
  3. 4.1.2 Troponin T (TnT)
  4. 4.2 Global Troponin Sales Volume by Type
  5. 4.2.1 Global Troponin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Troponin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Troponin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Troponin Sales Value by Type
  9. 4.3.1 Global Troponin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Troponin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Troponin Sales Value Share by Type (2021-2032)
5 Troponin Market by Application
  1. 5.1 Troponin Application Introduction
  2. 5.1.1 Myocardial Infarction
  3. 5.1.2 Acute Coronary Syndrome
  4. 5.1.3 Others
  5. 5.2 Global Troponin Sales Volume by Application
  6. 5.2.1 Global Troponin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Troponin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Troponin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Troponin Sales Value by Application
  10. 5.3.1 Global Troponin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Troponin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Troponin Sales Value Share by Application (2021-2032)
6 Troponin Regional Sales and Value Analysis
  1. 6.1 Global Troponin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Troponin Sales by Region (2021-2032)
  3. 6.2.1 Global Troponin Sales by Region: 2021-2026
  4. 6.2.2 Global Troponin Sales by Region (2027-2032)
  5. 6.3 Global Troponin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Troponin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Troponin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Troponin Sales Value by Region (2027-2032)
  9. 6.5 Global Troponin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Troponin Sales Value (2021-2032)
  12. 6.6.2 North America Troponin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Troponin Sales Value (2021-2032)
  15. 6.7.2 Europe Troponin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Troponin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Troponin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Troponin Sales Value (2021-2032)
  21. 6.9.2 South America Troponin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Troponin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Troponin Sales Value Share by Country, 2025 VS 2032
7 Troponin Country-level Sales and Value Analysis
  1. 7.1 Global Troponin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Troponin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Troponin Sales by Country (2021-2032)
  4. 7.3.1 Global Troponin Sales by Country (2021-2026)
  5. 7.3.2 Global Troponin Sales by Country (2027-2032)
  6. 7.4 Global Troponin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Troponin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Troponin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Troponin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Troponin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Troponin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Troponin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Troponin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Troponin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Troponin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Troponin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Troponin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Troponin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Troponin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Troponin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Troponin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Troponin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Troponin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Troponin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Troponin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Troponin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Troponin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Troponin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Troponin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Troponin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Troponin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Troponin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Troponin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Troponin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Troponin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Troponin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Troponin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Troponin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Troponin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Troponin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Troponin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Troponin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Troponin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Troponin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Troponin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Troponin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Troponin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Troponin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Troponin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Troponin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Troponin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Troponin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Troponin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Troponin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Troponin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Troponin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Troponin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Troponin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Troponin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Troponin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Troponin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Troponin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Troponin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Troponin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Troponin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Troponin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Troponin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Troponin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Troponin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Troponin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Troponin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Troponin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Troponin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Troponin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Troponin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Troponin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Troponin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Troponin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Troponin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Troponin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Troponin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Troponin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Troponin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Troponin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Troponin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Troponin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Troponin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Troponin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Troponin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Troponin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Troponin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Troponin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Troponin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Troponin Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Troponin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roche Troponin Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Siemens Healthcare
  14. 8.3.1 Siemens Healthcare Company Information
  15. 8.3.2 Siemens Healthcare Business Overview
  16. 8.3.3 Siemens Healthcare Troponin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Siemens Healthcare Troponin Product Portfolio
  18. 8.3.5 Siemens Healthcare Recent Developments
  19. 8.4 Beckman Coulter
  20. 8.4.1 Beckman Coulter Company Information
  21. 8.4.2 Beckman Coulter Business Overview
  22. 8.4.3 Beckman Coulter Troponin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beckman Coulter Troponin Product Portfolio
  24. 8.4.5 Beckman Coulter Recent Developments
  25. 8.5 Biomerieux
  26. 8.5.1 Biomerieux Company Information
  27. 8.5.2 Biomerieux Business Overview
  28. 8.5.3 Biomerieux Troponin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biomerieux Troponin Product Portfolio
  30. 8.5.5 Biomerieux Recent Developments
  31. 8.6 Mitsubishi
  32. 8.6.1 Mitsubishi Company Information
  33. 8.6.2 Mitsubishi Business Overview
  34. 8.6.3 Mitsubishi Troponin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mitsubishi Troponin Product Portfolio
  36. 8.6.5 Mitsubishi Recent Developments
  37. 8.7 Quidel
  38. 8.7.1 Quidel Company Information
  39. 8.7.2 Quidel Business Overview
  40. 8.7.3 Quidel Troponin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Quidel Troponin Product Portfolio
  42. 8.7.5 Quidel Recent Developments
  43. 8.8 Getein Biotech
  44. 8.8.1 Getein Biotech Company Information
  45. 8.8.2 Getein Biotech Business Overview
  46. 8.8.3 Getein Biotech Troponin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Getein Biotech Troponin Product Portfolio
  48. 8.8.5 Getein Biotech Recent Developments
  49. 8.9 Improve Medical
  50. 8.9.1 Improve Medical Company Information
  51. 8.9.2 Improve Medical Business Overview
  52. 8.9.3 Improve Medical Troponin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Improve Medical Troponin Product Portfolio
  54. 8.9.5 Improve Medical Recent Developments
  55. 8.10 Response Biomedical
  56. 8.10.1 Response Biomedical Company Information
  57. 8.10.2 Response Biomedical Business Overview
  58. 8.10.3 Response Biomedical Troponin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Response Biomedical Troponin Product Portfolio
  60. 8.10.5 Response Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Troponin Value Chain Analysis
  2. 9.1.1 Troponin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Troponin Sales Mode & Process
  6. 9.2 Troponin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Troponin Distributors
  9. 9.2.3 Troponin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst